A new AI system uses routine mammograms to identify women at high risk for cardiovascular disease by measuring breast arterial calcifications.
Key Details
- 1The AI tool is a transformer-based neural network that quantifies CVD risk based on breast arterial calcifications (BACs) seen in screening mammograms.
- 2Study included retrospective analysis of nearly 124,000 women from two healthcare systems.
- 3BACs were categorized as zero, mild, moderate, or severe, and these categories were correlated with future major adverse cardiovascular events.
- 4Routine mammography provides an accessible, cost-effective opportunity for early CVD risk detection in women.
- 5Research was led by Dr. Hari Trivedi at Emory University, Department of Radiology.
Why It Matters
This approach leverages widely performed breast screening to address underdiagnosis of heart disease in women, allowing early intervention for cardiovascular risk using imaging AI. If validated, it could integrate seamlessly into current screening practices and improve population health.
Source
Radiology Business
Related News
•Radiology Business
Real-World Study: Radiology AI Best in Emergency and Inpatient Settings
A commercial AI tool for intracranial aneurysm detection outperformed in inpatient and emergency settings but yielded limited benefits for outpatients in a major health system study.
•Radiology Business
New Rubric Enhances Safety of AI-Generated Radiology Summaries
Researchers developed a five-factor rubric to assess the safety and quality of AI-generated, patient-friendly radiology report summaries.
•Radiology Business
UCLA Review Evaluates Breast AI for Early Cancer Detection
A UCLA-led review analyzes current evidence for AI tools in screening mammography, focusing on their capability to detect interval cancers.